Clinical Trial to Assess Safety and Efficacy of Autologous Cultured Epidermal Grafts Containing Epidermal Stem Cells Genetically Modified in Patients With JEB (HOLOGENE17)
Clinical trial NCT03490331 · TERMINATED
Trial details
- NCT number
- NCT03490331
- Sponsor
- Holostem s.r.l.
- Status
- TERMINATED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-03-19
- Primary completion
- 2018-09-11
- Enrollment
- 1
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.